| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9394(03)00483-5 |
| P698 | PubMed publication ID | 14597028 |
| P50 | author | Darius M Moshfeghi | Q79439473 |
| Ingrid U. Scott | Q108861392 | ||
| P2093 | author name string | Hugo Quiroz-Mercado | |
| Timothy G Murray | |||
| Raj K Maturi | |||
| Peter K Kaiser | |||
| Sophie J Bakri | |||
| Jonathan E Sears | |||
| William F Mieler | |||
| Paul M Beer | |||
| Richard S Kaiser | |||
| Jonathan Belmont | |||
| Matthew Benz | |||
| Juan P Sinesterra | |||
| P2860 | cites work | Complications of surgery in glaucoma. Early and late bacterial endophthalmitis following glaucoma filtering surgery | Q69901564 |
| Late onset endophthalmitis associated with filtering blebs | Q69901567 | ||
| Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis | Q70215878 | ||
| Postoperative endophthalmitis in association with diabetes mellitus | Q72291491 | ||
| Endophthalmitis after secondary intraocular lens implantation. A case-report study | Q73212592 | ||
| Intravitreal triamcinolone and elevated intraocular pressure | Q73370937 | ||
| Risk factors for glaucoma filtering bleb infections | Q73559497 | ||
| ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography | Q30863659 | ||
| Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema | Q31005790 | ||
| Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation | Q31049320 | ||
| Intravitreal triamcinolone for refractory diabetic macular edema | Q31050662 | ||
| Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes | Q32101234 | ||
| The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells | Q34743332 | ||
| Local Therapy for Cytomegalovirus Retinopathy | Q40474798 | ||
| Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy | Q40714745 | ||
| Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity | Q40798430 | ||
| Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion | Q43009737 | ||
| Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis | Q43555872 | ||
| Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. | Q43571484 | ||
| Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells | Q43705240 | ||
| Glucocorticoid action on depolarization-dependent calcium influx in brain synaptosomes | Q48133051 | ||
| Glucocorticoid actions on synaptic plasma membranes: modulation of [125I]calmodulin binding | Q48182591 | ||
| The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. | Q54668829 | ||
| The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis | Q64133992 | ||
| Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil | Q67972025 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute endophthalmitis | Q18554163 |
| P304 | page(s) | 791-796 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | Acute endophthalmitis following intravitreal triamcinolone acetonide injection | |
| P478 | volume | 136 |
| Q39010103 | A Review of the Role of Intravitreal Corticosteroids as an Adjuvant to Antibiotics in Infectious Endophthalmitis. |
| Q33263803 | A review of drug options in age-related macular degeneration therapy and potential new agents |
| Q42075612 | Acute retinal necrosis after intraocular triamcinolone acetonide injection |
| Q42162292 | Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion |
| Q43923256 | Associated factors and treatment outcome of presumed noninfectious endophthalmitis occurring after intravitreal triamcinolone acetonide injection |
| Q61865944 | Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti–Vascular Growth Factor Agents in a Nationwide Study in France |
| Q83821053 | Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone |
| Q31146864 | Clinical trials on corticosteroids for diabetic macular edema |
| Q33395775 | Comparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema |
| Q34601246 | Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study |
| Q33507910 | Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema |
| Q46068036 | Comparison of surgical procedures for vitreous surgery in diabetic macular edema |
| Q41545792 | Comparison of the efficacy between an intravitreal and a posterior subtenon injection of triamcinolone acetonide for the treatment of diffuse diabetic macular edema |
| Q35009731 | Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema |
| Q33900514 | Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series. |
| Q46433890 | Complications of intravitreal injection of triamcinolone acetonide |
| Q38261106 | Complications of intravitreal injections in patients with diabetes |
| Q42116404 | Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema |
| Q37222318 | Dose dependent effects of intravitreal triamcinolone acetonide on diffuse diabetic macular edema |
| Q46063044 | Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure. |
| Q37953969 | Drug safety evaluation of intravitreal triamcinolone acetonide |
| Q36548120 | Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection |
| Q36906893 | Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections. |
| Q46121000 | Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis |
| Q40911617 | Effects of triamcinolone acetonide on human trabecular meshwork cells in vitro. |
| Q46259325 | Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation |
| Q24630848 | Emerging drugs for uveitis |
| Q33304852 | Emerging pharmacotherapies for diabetic macular edema |
| Q37544827 | Endophthalmitis after intravitreal injections |
| Q42771210 | Endophthalmitis associated with Glaucoma Shunt Intraluminal Stent Exposure. |
| Q46758682 | Endophthalmitis following new procedures |
| Q33234405 | Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection |
| Q33774225 | Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives |
| Q34952098 | Endophthalmitis: state of the art. |
| Q42545507 | Entrapment of intravitreal triamcinolone behind the crystalline lens |
| Q46880048 | Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits |
| Q33212693 | Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration. |
| Q80336578 | Globe rupture as a complication of intravitreal injection of triamcinolone |
| Q36311041 | Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy |
| Q43212996 | Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element |
| Q46121306 | Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection |
| Q37060329 | Intraocular inflammation following intravitreal injection of bevacizumab |
| Q91722691 | Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan |
| Q43257000 | Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes. |
| Q41859736 | Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema |
| Q38053198 | Intravitreal injections: a review of the evidence for best practice |
| Q46840516 | Intravitreal injections: a review of the evidence for best practice: comment |
| Q45032874 | Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema |
| Q58806282 | Intravitreal therapeutic agents in noninfectious uveitic macular edema |
| Q44854264 | Intravitreal triamcinolone acetonide Complication of infectious and sterile endophthalmitis |
| Q46954571 | Intravitreal triamcinolone acetonide for exudative age-related macular degeneration among Japanese patients |
| Q51935620 | Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. |
| Q79928598 | Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion |
| Q44780849 | Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases |
| Q36951178 | Intravitreal triamcinolone acetonide: a "real world" analysis of visual acuity, pressure and outcomes |
| Q36500994 | Intravitreal triamcinolone acetonide: a change in a paradigm |
| Q44641599 | Intravitreal triamcinolone and endophthalmitis |
| Q33219578 | Intravitreal triamcinolone for diffuse diabetic macular oedema |
| Q43096392 | Intravitreal triamcinolone for intraocular inflammation and associated macular edema |
| Q31146807 | Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series. |
| Q34015028 | Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema |
| Q33841803 | Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema |
| Q33325652 | Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema |
| Q46275348 | Intravitreous injection: retrospective study on 2028 injections and their side effects |
| Q33282848 | Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema |
| Q33530909 | Laser photocoagulation versus combined laser photocoagulation and posterior sub-Tenon's triamcinolone injection for the primary treatment of diffuse diabetic macular edema. |
| Q34636224 | Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application |
| Q33281020 | Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series |
| Q46647067 | Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis |
| Q36378901 | National survey of the technique of intravitreal triamcinolone injection in the United Kingdom |
| Q34161986 | Neodymium: yttrium-aluminum-garnet laser anterior hyaloidotomy to treat trapped triamcinolone acetonide behind the crystalline lens after intravitreal injection |
| Q46815609 | Noninfectious hypopion after intravitreal triamcinolone acetonide injection for central retinal vein occlusion: a case report |
| Q38616486 | Ocular Infection: Endophthalmitis |
| Q36482537 | Ocular morbidity associated with intravitreal triamcinolone acetonide |
| Q44780851 | Ocular side effects and complications of intravitreal triamcinolone acetonide injection |
| Q36700094 | One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy |
| Q91800069 | Optical coherence tomography findings predictive of response to treatment in diabetic macular edema |
| Q36943828 | Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy |
| Q35980294 | Phacoemulsification and intraocular lens implantation after inadvertent intracapsular injection of intravitreal dexamethasone implant |
| Q45075982 | Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study |
| Q33294882 | Pharmacotherapies for diabetic retinopathy: present and future |
| Q35769376 | Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye |
| Q42244312 | Pilot study of the delivery of microcollimated pars plana external beam radiation in porcine eyes: 270-day analysis |
| Q33306357 | Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion |
| Q35956280 | Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study |
| Q35572155 | Presumed necrotizing viral retinitis after intravitreal triamcinolone injection: case report |
| Q28076321 | Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention |
| Q36792992 | Retrospective analysis of etiopathogenesis of all cases of endophthalmitis at a large tertiary referral center |
| Q46926285 | Safety of Triamcinolone acetonide (TA)-assisted pars plana vitrectomy in macular hole surgery |
| Q43060156 | Scleral thickness following fluocinolone acetonide implant (Retisert). |
| Q35030923 | Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis). |
| Q41044420 | Study of the Acute Effects of Povidone-Iodine on Conjunctival Bacterial Flora |
| Q38964388 | Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane). |
| Q34001902 | Subtenon Vs Intravitreal Triamcinolone injection in Diabetic Macular Edema, A prospective study in Chinese population |
| Q34425420 | Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration |
| Q36217662 | The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates |
| Q24810825 | The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract |
| Q44972000 | The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections |
| Q53356359 | The effectiveness and reliability of posterior sub-Tenon triamcinolone acetonide injection in branch retinal vein occlusion-related macular edema. |
| Q80233172 | The ocular effects of intravitreal triamcinolone acetonide in dogs |
| Q36441711 | The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. |
| Q85818319 | The results of pars plana vitrectomy and silicone oil tamponade for endophthalmitis after intravitreal injections |
| Q46859846 | Trans-Tenon's retrobulbar injection of triamcinolone acetonide for diffuse diabetic macular edema |
| Q33219602 | Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy |
| Q33272746 | Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes |
| Q46623005 | Triamcinolone acetonide suppresses interleukin-1 beta-mediated increase in vascular endothelial growth factor expression in cultured rat Müller cells |
| Q53458423 | Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization. |
| Q28074846 | Update on corticosteroids for diabetic macular edema |
| Q36977430 | Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration |
| Q46923860 | Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density |
| Q34000099 | Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities |
| Q37526600 | Visualizing vitreous in vitrectomy by triamcinolone |
| Q46859796 | Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide |
| Q79820540 | [Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration] |
Search more.